Peptide research collaboration
A collaborative research agreement has been announced between Biotage and the Laboratory of Peptide and Protein Chemistry and Biology in Florence, Italy.
A collaborative research agreement has been announced between Biotage and the Laboratory of Peptide and Protein Chemistry and Biology (PeptLab) in Florence, Italy. The peptide research facility, led by Professor Anna Maria Papini, will contribute technical input towards the future development of Biotage related products as well as provide training facilities for demonstrating the company’s range of peptide synthesis, purification and resin products.
“Biotage is very fortunate to have the opportunity to collaborate with Professor Papini and the PeptLab team,” said Torben Jörgensen, president and CEO of Biotage. “We are all very excited by the opportunity to work with this prestigious group and are looking forward to our collaboration across a wide range of activities.”
PeptLab is an interdepartmental structure of the University of Florence, created to organize a European Innovation Network to introduce a “Quality Approach” for R&D activities in academic laboratories and SMEs, providing Good Practice Guidance, initially in the field of peptide-based diagnostics.
Professor Papini remarked, “It is evident that the cooperation with Biotage fits perfectly with our goals both within PeptLab itself and the wider framework of the European Innovation Network. It is for this reason that we decided to invest in the Biotage Syro II and Syro Wave parallel peptide synthesizers for our SOSCO Laboratory in Cergy-Pontiose.”
For more information on PeptLab, visit www.unifi.it/peptlab
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
